SCHEMBL5723705

SCHEMBL5723705

NC(=O)CCc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.50
PRMT1 Q99873 1/20 0.50
ALDH1A1 P00352 5/20 0.45
HSD17B10 Q99714 4/20 0.45
CYP3A4 P08684 3/20 0.45
TSHR P16473 2/20 0.45
RECQL P46063 2/20 0.45
HSP90AA1 P07900 1/20 0.45
CYP2C9 P11712 2/20 0.44
AKR1C4 P17516 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7344359 0.84 GPR17 (0.54) CYP1A2PRMT1ALDH1A1HSD17B10CYP3A4
SCHEMBL11505512 0.80 HSD17B10 (0.62) CYP1A2PRMT1ALDH1A1HSD17B10CYP3A4
SCHEMBL2849945 0.76 PDPK1 (0.54) CYP1A2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL31346720 0.76 PDPK1 (0.54) CYP1A2ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL7195008 0.76 GRM5 (0.49) ALDH1A1HSD17B10HSP90AA1HPGDMEN1
SCHEMBL16150317 0.76 CAPN1 (0.43) CYP1A2ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL5724266 0.75 ALOX15 (0.55) ALDH1A1HSD17B10CYP3A4TSHRHSP90AA1
SCHEMBL2974181 0.75 CYP1A2 (0.59) CYP1A2PRMT1ALDH1A1HSD17B10CYP3A4
SCHEMBL1304790 0.75 ATM (0.35) CYP2C9CYP2C19SLC6A3SMN1; SMN2HIF1A
SCHEMBL13816977 0.72 CYP3A4 (0.56) CYP1A2PRMT1ALDH1A1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633715-A1 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS Pfizer Limited (GB) 2006-03-15 EP disclosed
WO-2004108676-A1 2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS PFIZER LIMITED (GB) 2004-12-16 WO disclosed